Abstract
A quantitative method for circulating islet cell surface antibodies (ICSA), based on the binding of125I-protein A to insulin-producing RINm5F cells, was used to evaluate ICSA in plasma of 4- to 40-week-old Aston obese hyperglycaemic (ob/ob) mice and normal control (+/+) mice. RINm5F cells bound 2502±l196 c.p.m.125I-protein A per l05 cells (mean±S.D.,n=54) after incubation with +/+ plasma. ICSA positive plasma (defined as125I-protein A binding, mean±2 S.D. of +/+ plasma) was detected in 3 out of 54+/+ mice and 3 out of 54 ob/ob mice. ICSA were not observed in ob/ob mice before the onset of diabetes (7 weeks of age), but were detected at 9, 20 and 40 weeks. At 20 weeks125I-protein A binding produced by ob/ob plasma was 35% greater than +/+ plasma (P<0.05). The low occurrence of ICSA in ob/ob mice (6%) suggests that factors other than ICSA are responsible for B-cell dysfunction and eventual islet degeneration observed in Aston ob/ob mice.
Similar content being viewed by others
References
Lernmark A, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ & Traisman HS (1978) Islet cell surface antibodies in juvenile diabetes mellitus. N. Engl. J. Med.229, 375–380.
Lernmark A, Hagglof B, Freedman ZR, Irvine WJ, Ludvigsson J & Holmgren G (1981) A prospective analysis of antibodies reactive with pancreatic islet cells in insulin-dependent diabetic children. Diabetologia20, 573–577.
Dyrberg T, Nakhooda AF, Baekkeskov S, Lernmark A, Poussier P & Marliss EB (1982) Islet cell surface antibodies and lymphocyte antibodies in the spontaneously diabetic BB Wistar rat. Diabetes31, 278–281.
Dyrberg T, Poussier P, Nakhooda F, Marliss EB and Lernmark A (1984) Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat. Diabetologia26, 159–165.
Toyota T, Goto Y, Kataoka S, Fujiya H, Sato J, Oya K, Shintani S & Kumagai K (1984) Immunologic studies on NOD mice as a model of IDDM. In:Lessons from Animal Diabetes (Shafrir E & Renold AE, eds), pp 308–314, John Libbey, London.
Howard CF & Fang TY (1984) Circulating antibodies to islet cells in prediabetic and diabeticMacaca nigra. In:Lessons from Animal Diabetes (Shafrir E & Renold AE, eds), pp 277–283, John Libbey, London.
Lernmark A (1985) Molecular biology of type 1 (insulin-dependent) diabetes mellitus. Diabetologia28, 195–203.
Dobersen MJ & Scharff JE (1982) Preferential lysis of pancreatic B-cells by islet cell surface antibodies. Diabetes31, 459–462.
Kanatsuna T, Lernmark A, Rubenstein AH & Steiner DF (1981) Blocking insulin release from column-perifused pancreatic beta cells induced by cell surface antibodies and complement. Diabetes30, 231–234.
Kanatsuna T, Backkeskov S, Lernmark A & Ludvigsson J (1983) Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes32, 520–524.
Flatt PR & Bailey CJ (1981) Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia20, 573–577.
Bailey CJ, Flatt PR & Atkins TW (1982) Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice. Int. J. Obes.6, 11–21.
Stevens JF (1971) Determination of glucose by automatic analyser. Clin. Chim. Acta32, 199–201.
Huen AH-J, Haneda M, Freedman Z, Lernmark A & Rubenstein AH (1983) Quantitative determination of islet B-cell surface antibodies using125I-protein A. Diabetes32, 460–465.
Gazdar AF, Chick WL, Oie HK, Sims HL, King DL & Lauris L (1980) Continuous, clonal insulin- and somatostatin-secreting cell lines established from a transplantable rat islet cell tumour. Proc. Natl. Acad. Sci. U.S.A.77, 3519–3523.
Chandra RK (1980) Cell-mediated immunity in genetically obese (C57BL/6J ob/ob) mice. Amer. J. Clin. Nutr.33, 13–16.
Langone JJ (1978)125I-protein A: a tracer for general use in immunoassay. J. Immunol. Methods24, 269–285.
Richman DD, Cleveland PH, Oxman MN & Johnson KM (1982) The binding of Staphylococcal protein A by the sera of different animal species. J. Immunol.128, 2300–2305.
Flatt PR & Bailey CJ (1981) Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice. Horm. Metab. Res.13, 556–560.
Flatt PR & Bailey CJ (1982) Plasma glucose and insulin responses to glucagon and arginine in Aston ob/ob mice: evidence for a selective defect in glucose-mediated insulin release. Horm. Metab. Res.14, 127–130.
Flatt PR & Bailey CJ (1984) Neural involvement in the insulin response to feeding in obese hyperglycaemic (ob/ob) mice. In:Lessons from Animal Diabetes (Shafrir E & Renold AE, eds), pp 158–162, John Libbey, London.
Flatt PR, Bailey CJ, Kwasowski P, Page T & Marks V (1984) Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. J. Endocrinol.101, 249–256.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Flatt, P.R., Bone, A.J. & Bailey, C.J. Islet cell surface antibodies in genetically obese hyperglycaemic (ob/ob) mice. Biosci Rep 5, 715–720 (1985). https://doi.org/10.1007/BF01119868
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01119868